MHRA Approves UK’s First Nasal Spray for Anaphylaxis
An adrenaline nasal spray for the emergency treatment of anaphylaxis has been approved by the Medicines and Healthcare…
Doubt Cast on the Need for Long-Term Antidepressant Tapering
The majority of symptoms reported by patients after stopping antidepressants are mild and do not meet the criteria…
UK Valproate Restrictions in Men Justified? New Data
A large Danish cohort study showed no significant increase in neurodevelopmental disorders (NDDs) among children fathered by men…
Methotrexate Adds No Benefit to Adalimumab in Psoriasis
TOPLINE: In adults with psoriasis, adding methotrexate to adalimumab did not improve effectiveness or drug survival compared with…
UK Pharmacies Struggle with Severe Creon Shortage
Nearly all UK pharmacies are experiencing severe “challenges” supplying pancreatic enzyme replacement therapy (PERT), the National Pharmacy Association…
EMA Changes Azithromycin Use to Combat Antibiotic Resistance
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended several changes to the way the…
New Genetic Test Could Diagnose Brain Tumours in 2 Hours
Researchers at the University of Nottingham have developed a new genetic test that can diagnose brain tumours in…
Are Europe’s Specialist Centers the Answer to Endometriosis?
Endometriosis affects roughly 190 million (10%) women and girls of reproductive age globally. Still, and despite its debilitating…
RA Remission Rates Vary in England and Wales
TOPLINE: Although remission rates of patients with early rheumatoid arthritis (RA) remained stable between 2018 and 2024 in…
Rare Acromegaly Case Reveals Genetic Link and Cardiac Issues
Key Takeaways A 23-year-old man was admitted to the hospital with severe dyspnoea, elevated body temperature, and rhinorrhoea.…